Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
The Korean Journal of Internal Medicine
;
: 63-66, 2007.
Artigo
em Inglês
| WPRIM
| ID: wpr-182817
ABSTRACT
Inhibitors of tumor necrosis factor-alpha (TNF-alpha) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic arthritis and inflammatory bowel disease. While etanercept is effective, certain infectious complications, such as tuberculosis, fungus, and cytomegalovirus, have been reported. We report the first Korean case of adenoviral pneumonia in a 55-year-old female who developed disseminated adenoviral infection following etanercept treatment, which resolved after anti-TNF-alpha discontinuation.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Artrite Reumatoide
/
Proteínas Recombinantes de Fusão
/
Imunoglobulina G
/
Infecções por Adenovirus Humanos
/
Fatores de Risco
/
Hospedeiro Imunocomprometido
/
Receptores do Fator de Necrose Tumoral
/
Antirreumáticos
/
Anticorpos Monoclonais
Tipo de estudo:
Estudo de etiologia
/
Fatores de risco
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
The Korean Journal of Internal Medicine
Ano de publicação:
2007
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS